Bictegravir is a second-generation integrase strand transfer inhibitor (INSTI) used as a pharmaceutical raw material for the manufacturing of antiretroviral therapies. As a monocarboxylic acid amide, This compound is a key active ingredient in combination tablets for HIV-1 treatment.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1611493-60-7
2,5-Methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, 2,3,4,5,7,9,13,13a-octahydro-8-methoxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-, (2R,5S,13aR)-
pharmaceutical intermediate
3b-17-Imino-androst-5-en-3-ol Acetate Dimer
pharmaceutical raw material
Niraparib tosylate monohydrate
pharmaceutical raw material
Zerbaxa
pharmaceutical raw material
2',3'-di-O-acetyl-5'-deoxy-5-fluorocytidine
pharmaceutical raw material
Bictegravir sodium
pharmaceutical raw material
(1S,11R,13R)-5-hydroxy-3,6-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-12-oxa-2,9-diazatetracyclo[11.2.1.02,11.04,9]hexadeca-4,7-diene-7-carboxamide
SOLUWJRYJLAZCX-LYOVBCGYSA-N
C1C[C@@H]2C[C@H]1N3[C@H](O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F